Quanome Technologies, Inc.: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 19, 2026 and accepted by EDGAR at May 19, 2026, 17:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $1.3m | us-gaap:Revenues |
| Revenue | 9 months2025-07-01 to 2026-03-31 | $5.1m | us-gaap:Revenues |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $348.2k | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-07-01 to 2026-03-31 | $2.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $979.5k | us-gaap:GrossProfit |
| Gross profit | 9 months2025-07-01 to 2026-03-31 | $2.8m | us-gaap:GrossProfit |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$1.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-07-01 to 2026-03-31 | −$3.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $26.7k | us-gaap:InterestExpenseNonoperating |
| Interest expense | 9 months2025-07-01 to 2026-03-31 | $149.4k | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $29.6k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-07-01 to 2026-03-31 | $110.6k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $142.4k | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-07-01 to 2026-03-31 | −$2.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-07-01 to 2026-03-31 | −$0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $0.01 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-07-01 to 2026-03-31 | −$0.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 34,427,559 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-07-01 to 2026-03-31 | 22,826,266 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-07-01 to 2026-03-31 | −$3.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | At period end2026-03-31 | $1.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $17.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $17.8m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $4.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $4.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $13.6m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2026-03-31 | 34,427,559 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001213900-26-059117. Last ingested by Listed: Oct 29, 2026, 08:16 ET. Listed shows no prices and gives no investment advice.